Clinical Study

Impact of Insulin Resistance on Silent and Ongoing Myocardial Damage in Normal Subjects: The Takahata Study

Table 4

Comparisons of clinical characteristics of patients with and without IR and Mets in male.

IR (−) IR (+) Mets (+)

Age (years) 64 ± 10 64 ± 10 63 ± 8
BMI (kg/m2) 22.0 ± 3.024.2 ± 2.8* 25.9 ± 2.3*#
sBP (mm Hg)135 ± 16 138 ± 16*142 ± 13*
dBP (mm Hg)81 ± 10 83 ± 10 85 ± 9*
BNP (pg/mL) 19.8 (10.2–37.6) 13.8 (8.0–31.8)*14.2 (8.0–28.7)*
TC (mg/dL) 189 (170–207)197 (179–215)*196 (173–224)*#
TG (mg/dL) 84 (64–111)104 (79–135)*184 (151–256)*
HDLc (mg/dL) 59 ± 14 54 ± 12*43 ± 12*#
LDLc (mg/dL) 117 ± 28 128 ± 27*123 ± 29*#
eGFR (mL/min/1.73 m2) 83 (72–92) 76 (66–86)*77 (67–89)*
H-FABP (ng/mL) 3.2 (2.4–4.5) 3.6 (2.7–4.8)*3.8 (2.8–4.9)*

BMI: body mass index; BNP: brain natriuretic peptide; TC: total cholesterol; TG: triglyceride; HDLc: high density lipoprotein cholesterol; LDLc: low density lipoprotein cholesterol; H-FABP: heart type fatty acid binding protein; sBP: systolic blood pressure; dBP: diastolic blood pressure; Data are presented as mean ± S.D or median (interquartile range). *P < 0.05 versus IR (−); #P < 0.05 versus IR (+).